Aris Liakos

Assistant Professor in Internal Medicine, Educator & Proponent of Evidence-Based Medicine

[EASD @EASDnews]

📊Join us later today for the EASD guideline symposium on #CGM in type 2 #diabetes.

📅 30 Sept 2026 | 16:30 CEST |📍London Hall
Chaired by Prof. Amanda Adler & Prof. Dame Melanie J. Davies.

🎙️Revisit their interview 👉
https://t.co/T5UTDnVsS5

More👉 https://t.co/GW78EcDzQg

[EASD @EASDnews]

📢 Have your say! EASD's draft #guideline on continuous glucose monitoring (CGM) in #T2D is live & open for consultation! We invite HCPs, researchers & PLWDs: review & share feedback to help shape the final version.

🗓️ 21 July - 4 Aug 2026

👉Review here: https://t.co/NK2awP9up1

[Aris Liakos @arliakos]

New call for applications for the MSc in Medical Research Methodology! More information available at https://t.co/HWat3SQuId.

[Aris Liakos @arliakos]

New call for applications for the MSc in Medical Research Methodology! More information available at https://t.co/HWat3SQuId.

[Aris Liakos @arliakos]

Evidence-based medicine has already adapted and is very much alive https://t.co/H4EkjBMVYk

[Martin Landray @MartinLandray]

This is the 3rd immuno-modulatory (anti-inflammatory) drug shown to save lives in RECOVERY:
- dexamethasone (June 2020)
- tocilizumab (Feb 2021)
- baricitinib (Mar 2022)

We now know that for some pts they can be used in combination to lower the risk of death by >50%.

[METRICStanford @METRICStanford]

"Educating educators on research on research"
John P. A. Ioannidis, Perspectives on Medical Education (2021)

https://t.co/wR99SupfXk

[Informed Health Choices @IHC_project]

Our primary school resources are now available in Greek! 🇬🇷 An early, freely available Xmas gift from @cebm_auth, @atsapas and @arliakos. 🎄 #in4medchoices

https://t.co/cbJeBPg2Tq

[CEBM AUTh @cebm_auth]

Visit our new website on http://t.co/pBrEbDDDLO